NM_001024630.4:c.1531G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001024630.4(RUNX2):​c.1531G>A​(p.Gly511Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0104 in 1,614,152 control chromosomes in the GnomAD database, including 95 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0083 ( 8 hom., cov: 32)
Exomes 𝑓: 0.011 ( 87 hom. )

Consequence

RUNX2
NM_001024630.4 missense

Scores

4
6
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 9.60

Publications

11 publications found
Variant links:
Genes affected
RUNX2 (HGNC:10472): (RUNX family transcription factor 2) This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Two regions of potential trinucleotide repeat expansions are present in the N-terminal region of the encoded protein, and these and other mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. [provided by RefSeq, Jul 2016]
RUNX2 Gene-Disease associations (from GenCC):
  • cleidocranial dysplasia 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 29 curated pathogenic missense variants (we use a threshold of 10). The gene has 4 curated benign missense variants. Gene score misZ: 1.6033 (below the threshold of 3.09). Trascript score misZ: 1.7818 (below the threshold of 3.09). GenCC associations: The gene is linked to cleidocranial dysplasia 1, metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.008539617).
BP6
Variant 6-45547270-G-A is Benign according to our data. Variant chr6-45547270-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 357096.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0083 (1264/152302) while in subpopulation NFE AF = 0.0114 (777/68030). AF 95% confidence interval is 0.0108. There are 8 homozygotes in GnomAd4. There are 620 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1264 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RUNX2NM_001024630.4 linkc.1531G>A p.Gly511Ser missense_variant Exon 9 of 9 ENST00000647337.2 NP_001019801.3 Q13950-1
RUNX2NM_001369405.1 linkc.1489G>A p.Gly497Ser missense_variant Exon 7 of 7 NP_001356334.1
RUNX2NM_001015051.4 linkc.1465G>A p.Gly489Ser missense_variant Exon 8 of 8 NP_001015051.3 Q13950-3
RUNX2NM_001278478.2 linkc.1423G>A p.Gly475Ser missense_variant Exon 6 of 6 NP_001265407.1 Q32MY8A0A0D9SEN7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RUNX2ENST00000647337.2 linkc.1531G>A p.Gly511Ser missense_variant Exon 9 of 9 NM_001024630.4 ENSP00000495497.1 Q13950-1

Frequencies

GnomAD3 genomes
AF:
0.00831
AC:
1264
AN:
152184
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00442
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00714
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0150
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0114
Gnomad OTH
AF:
0.00860
GnomAD2 exomes
AF:
0.00764
AC:
1919
AN:
251052
AF XY:
0.00792
show subpopulations
Gnomad AFR exome
AF:
0.00425
Gnomad AMR exome
AF:
0.00454
Gnomad ASJ exome
AF:
0.00179
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0121
Gnomad NFE exome
AF:
0.0114
Gnomad OTH exome
AF:
0.00996
GnomAD4 exome
AF:
0.0106
AC:
15454
AN:
1461850
Hom.:
87
Cov.:
31
AF XY:
0.0103
AC XY:
7514
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00373
AC:
125
AN:
33480
American (AMR)
AF:
0.00463
AC:
207
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00191
AC:
50
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00196
AC:
169
AN:
86256
European-Finnish (FIN)
AF:
0.0121
AC:
649
AN:
53420
Middle Eastern (MID)
AF:
0.00312
AC:
18
AN:
5766
European-Non Finnish (NFE)
AF:
0.0123
AC:
13649
AN:
1111974
Other (OTH)
AF:
0.00972
AC:
587
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
851
1702
2554
3405
4256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
510
1020
1530
2040
2550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00830
AC:
1264
AN:
152302
Hom.:
8
Cov.:
32
AF XY:
0.00832
AC XY:
620
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00440
AC:
183
AN:
41556
American (AMR)
AF:
0.00713
AC:
109
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4826
European-Finnish (FIN)
AF:
0.0150
AC:
159
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0114
AC:
777
AN:
68030
Other (OTH)
AF:
0.00851
AC:
18
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
70
140
210
280
350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00936
Hom.:
22
Bravo
AF:
0.00804
TwinsUK
AF:
0.0116
AC:
43
ALSPAC
AF:
0.0132
AC:
51
ESP6500AA
AF:
0.00340
AC:
15
ESP6500EA
AF:
0.0114
AC:
98
ExAC
AF:
0.00812
AC:
986
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RUNX2: BS1, BS2 -

Oct 18, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 17, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 30, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32360898) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cleidocranial dysostosis Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

May 31, 2018
SIB Swiss Institute of Bioinformatics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant is interpreted as a Benign, for Cleidocranial dysplasia, in Autosomal Dominant manner. The following ACMG Tag(s) were applied: BS1 => Allele frequency is greater than expected for disorder. BS2 => Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age (PMID:10521292). -

Cleidocranial dysostosis;C3549874:Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome Benign:1
Aug 25, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.14
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.50
.;D;D;D;.;.;T
Eigen
Pathogenic
0.88
Eigen_PC
Pathogenic
0.89
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D;.;.;D;.;D;D
MetaRNN
Benign
0.0085
T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.2
.;M;M;M;.;.;.
PhyloP100
9.6
PrimateAI
Uncertain
0.79
T
PROVEAN
Uncertain
-2.8
.;D;.;D;D;D;.
REVEL
Uncertain
0.33
Sift
Benign
0.070
.;T;.;T;T;T;.
Sift4G
Benign
0.096
T;T;.;T;T;T;T
Polyphen
1.0
.;D;D;D;.;D;.
Vest4
0.46
MVP
0.56
MPC
1.6
ClinPred
0.016
T
GERP RS
5.8
Varity_R
0.49
gMVP
0.48
Mutation Taster
=42/58
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11498198; hg19: chr6-45515007; API